JOSD1 and malignant colon neoplasm: Furthermore, subsequent experiments involving the depletion of YAP in colon cancer cells demonstrated a significant reduction in YAP binding to the JOSD1 promoter region, as evidenced by the ChIP assay results (Fig. 7C, D).